A recent study found no correlation between UA levels and disease severity in untreated PD patients, but found that lower UA levels were significantly associated with lower dopamine transporter binding in the caudate, putamen, and striatum (Moccia et al., 2015). Here, SLC6A3 is linked to Parkinson disease.